BioMatrix versus Orsiro biodegradable polymer stents in all-comer patients with coronary artery disease: the multicentre, randomised BIODEGRADE trial.

Chang-Hwan Yoon,Young Jin Choi,Jin Joo Park,Si-Hyuck Kang,Sun-Hwa Kim,Jung-Won Suh,Young-Seok Cho,Tae-Jin Youn,Myeong-Kon Kim,Kwang Soo Cha, Seung-Hwan Lee,Bum-Kee Hong,Seung-Woon Rha,Woong-Chol Kang,Jae-Hwan Lee,Sang-Hyun Kim,In-Ho Chae

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology（2021）

Cited 7|Views63

No score

Abstract

In patients with a high prevalence of acute coronary syndrome, Orsiro stents were not inferior to BioMatrix stents. Both showed good clinical outcomes.

Translated text

Key words

ACS, NSTE-ACS, drug-eluting stent, stable angina, STEMI

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined